Medicine and Dentistry
COVID-19
76%
Cerebellar Ataxia
57%
Magnetic Resonance Imaging
44%
Sarcoma
38%
Amyotrophic Lateral Sclerosis
38%
Sjoegren Syndrome
38%
Nitrous Oxide
38%
Noninvasive Ventilation
38%
Ethnic Minority Group
38%
Severe Acute Respiratory Syndrome Coronavirus 2
38%
Clinical Neuroscience
38%
Infection
38%
Ethnic Disparity
38%
Patient Selection
38%
Disorders of Mitochondrial Functions
38%
Case-Control Study
38%
Trigeminal Neuralgia
25%
Family History
25%
Myoclonus
25%
Symptom
19%
Recreational Drug
19%
Observational Study
19%
Lower Limb
19%
Potential Barrier
19%
Paresthesia
19%
Methylmalonic Acid
19%
Awareness
19%
Cyanocobalamin
19%
Ataxic Gait
19%
Slurred Speech
19%
Neurologic Disease
19%
Ethnic Groups
19%
Neurological Complication
19%
Upper Limb
19%
Respiratory Failure
18%
Infusion
12%
Diseases
12%
Vertigo
12%
Motor Neuron Disease
12%
Mixed Connective Tissue Disease
12%
Hemifacial Spasm
12%
Stiff Person Syndrome
12%
Skew Deviation
12%
Facial Nerve Paralysis
12%
Exon
12%
Neck Muscle
12%
Weakness
12%
Nonsense Mutation
12%
Cyclophosphamide
12%
Pelvis
12%
Neuroscience
Ataxia
76%
Myasthenia gravis
61%
Azathioprine
50%
Magnetic Resonance Imaging
50%
Dysarthria
38%
Brainstem
38%
Rituximab
38%
Sjogren's Syndrome
38%
Posterior Cranial Fossa
38%
Hydrocephalus
38%
Amyotrophic Lateral Sclerosis
38%
Hypertension
38%
Myoclonus
31%
Trigeminal Neuralgia
25%
Intravenous Immunoglobulin
25%
Warfarin
19%
Cerebral Peduncle
19%
Fourth Ventricle
19%
Cerebellar Hemisphere
19%
Headache
19%
Congenital Disorder
19%
Methotrexate
19%
Pons
19%
Heparin
19%
Lateral Ventricle
19%
Differential Diagnosis
19%
Oligoclonal Band
19%
Mitochondrial DNA
19%
Autoimmune Disease
19%
Vitamin E
19%
Fragile X Syndrome
19%
Cognitive Disorders
19%
Spinocerebellar Ataxia
19%
Epileptic Absence
19%
Tonic-Clonic Seizure
19%
Statin
19%
ACE Inhibitor
19%
Immunosuppressive Drug
17%
Exon
12%
Nonsense Mutation
12%
Stiff Person Syndrome
12%
Cyclophosphamide
12%
Optic Neuritis
12%
Diplopia
12%
DNA Sequencing
12%
Motor Neuron Disease
12%
Electromyography
12%
Pelvis
12%
Electroencephalography
12%
TNF Inhibitor
12%
Pharmacology, Toxicology and Pharmaceutical Science
Myasthenia gravis
100%
Azathioprine
76%
Side Effect
66%
Mycophenolic Acid
66%
Methotrexate
57%
Rituximab
38%
Case-Control Study
38%
Immunosuppressive Agent
28%
Biosimilar Agent
19%
Disease Severity
19%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
19%
Adverse Event
19%
Dipeptidyl Carboxypeptidase Inhibitor
19%
Tolerability
12%
Liver Dysfunction
6%
Teratogenicity
6%
Diarrhea
6%